Lateral Flow Assay for Detection of Through Tumor Necrosis Factor Alpha (Infliximab) levels

Lateral Flow Assay for Detection of Through Tumor Necrosis Factor Alpha (Infliximab) levels - Lateral flow assay for TNF detection

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32551

Enrollment

Registered

2009-04-08

Start date

2009-12-04

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Crohn's disease, infliximab therapy

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
To test the feasibillity of lateral flw assay for measuring infliximab drug levels	—

Secondary

Measure	Time frame
Not appropiate	—

Countries

Netherlands

Outcome results